Literature DB >> 19880183

The yeast Candida albicans evades human complement attack by secretion of aspartic proteases.

Katharina Gropp1, Lydia Schild, Susann Schindler, Bernhard Hube, Peter F Zipfel, Christine Skerka.   

Abstract

Candida albicans, which represents one of the most important human pathogenic yeasts, is directly attacked by the host innate immune system upon infection. However this pathogen has developed multiple strategies to escape host immune defense. Here, we show that C. albicans secreted proteases interfere and inactivate host innate immune effector components, such as complement proteins. Secreted aspartic proteases (Saps) in the culture supernatant of C. albicans cells and also recombinant Sap1, Sap2 and Sap3 degrade host complement components C3b, C4b and C5 and also inhibit terminal complement complex (TCC) formation. This proteolytic activity is specific to the three recombinant and wild type Sap proteins. The triple knock out C. albicans strain Delta sap1-3 and also the non-pathogenic yeast S. cerevisiae lack such degrading activities. The complement inhibitory role of Sap1, Sap2 and Sap3 was confirmed in hemolysis assays with rabbit erythrocytes and normal human plasma. Secretion of complement degrading proteases provides a highly efficient complement defense response of this human pathogenic yeast that acts after the immediate acquisition of host complement regulators to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880183     DOI: 10.1016/j.molimm.2009.08.019

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  55 in total

1.  Proteolytic cleavage of covalently linked cell wall proteins by Candida albicans Sap9 and Sap10.

Authors:  Lydia Schild; Antje Heyken; Piet W J de Groot; Ekkehard Hiller; Marlen Mock; Chris de Koster; Uwe Horn; Steffen Rupp; Bernhard Hube
Journal:  Eukaryot Cell       Date:  2010-11-19

Review 2.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 3.  Development and regulation of single- and multi-species Candida albicans biofilms.

Authors:  Matthew B Lohse; Megha Gulati; Alexander D Johnson; Clarissa J Nobile
Journal:  Nat Rev Microbiol       Date:  2017-10-03       Impact factor: 60.633

Review 4.  Fungal proteases and their pathophysiological effects.

Authors:  Iwona Yike
Journal:  Mycopathologia       Date:  2011-01-23       Impact factor: 2.574

5.  Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5.

Authors:  Judith Behnsen; Franziska Lessing; Susann Schindler; Dirk Wartenberg; Ilse D Jacobsen; Marcel Thoen; Peter F Zipfel; Axel A Brakhage
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

6.  Evaluation of gene expression SAP5, LIP9, and PLB2 of Candida albicans biofilms after photodynamic inactivation.

Authors:  Fernanda Freire; Patrícia Pimentel de Barros; Damara da Silva Ávila; Graziella Nuernberg Back Brito; Juliana Campos Junqueira; Antonio Olavo Cardoso Jorge
Journal:  Lasers Med Sci       Date:  2015-04-28       Impact factor: 3.161

7.  An Opaque Cell-Specific Expression Program of Secreted Proteases and Transporters Allows Cell-Type Cooperation in Candida albicans.

Authors:  Matthew B Lohse; Lucas R Brenes; Naomi Ziv; Michael B Winter; Charles S Craik; Alexander D Johnson
Journal:  Genetics       Date:  2020-08-24       Impact factor: 4.562

Review 8.  Development of vaccines for Candida albicans: fighting a skilled transformer.

Authors:  Antonio Cassone
Journal:  Nat Rev Microbiol       Date:  2013-12       Impact factor: 60.633

Review 9.  Candida albicans biofilms: development, regulation, and molecular mechanisms.

Authors:  Megha Gulati; Clarissa J Nobile
Journal:  Microbes Infect       Date:  2016-01-22       Impact factor: 2.700

Review 10.  Overview of carbon and nitrogen catabolite metabolism in the virulence of human pathogenic fungi.

Authors:  Laure Nicolas Annick Ries; Sarah Beattie; Robert A Cramer; Gustavo H Goldman
Journal:  Mol Microbiol       Date:  2017-12-29       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.